Roche Holding Ltd.
Roche Holding Ltd.
Grenzacherstrasse 124, Basel, Switzerland
Public Pink Sheets: RHHBY
Roche Holding Ltd (also called F. Hoffmann-La Roche) is a Switzerland-based pharmaceuticals and diagnostics company. It sells its products in more than 150 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan and Herceptin, anemia treatment NeoRecormon/Epogin, hepatitis drug Pegasys, transplant drug CellCept, obesity treatment Xenical, and Tamiflu, which is used to prevent and treat influenza, including avian strains. The company markets many of its bestsellers through subsidiary Genentech and affiliate Chugai Pharmaceutical. Roche's diagnostics arm offers advanced DNA tests, diabetes monitoring supplies, and point-of-care diagnostics used in a variety of health care settings.
 Political Influence
- Lobbying Spending Database: Roche Group "Total Lobbying Expenditures: $8,290,772"
 Business Ethics
- Roche Officers Say Scandal Is a Surprise "One day after admitting that some senior executives were ringleaders in a nine-year price-fixing cartel for vitamins, the chairman and the chief executive of Roche Holding A.G. pronounced themselves blameless and clueless today. "You will understand that this was not part of our responsibility," said Franz B. Humer, the chief executive. "It is certainly not easy to understand the reasons for actions of employees who in secrecy organized a conspiracy of this kind." Roche, a pharmaceutical conglomerate based here, was by far the biggest player in what the United States Justice Department has described as a sophisticated cartel to fix worldwide vitamin prices as much as 25 percent above the market level."
- Roche Group Returns to Its Roots "In 1999, the company and other drug makers were hit with criminal fines and paid to settle charges that they colluded to inflate wholesale prices that hundreds of food and beverage companies paid for vitamins added to their products. Then its huge investment portfolio, which generated about one-fourth of revenue in 2000, began losing money as world markets plunged."
 Brands and Subsidiaries
- Accu-Chek, Accutrend, Acterma, Anaprox, Avastin, Bactrim, Bondronat, Boniva
- Cedex HiRes, CellCept, Coasys, Cobas, Combur-Test, Dilatrend, Dormicum, Fuzeon
- Herceptin, Invirase, Kytril, Lariam, LightCycle, Lucentis, MabThera, Madopar, Mircera, Neupogen, Pegasys
- Pulmozyme, Rocaltrol, Rocephin, Roferon-A, Tamiflu, Tarceva, Toradol, Valcyte, Valium
- Vesanoid, VIAS, Viracept, Xeloda, Xenical, Zenapax
- Genentech and affiliate Chugai Pharmaceutical